Tomeglovir is a novel nonnucleoside inhibitor of human cytomegalovirus replication. The molecular weight of the compound is 441.5432, and its molecular formula is C23H27N3O4S.
Molecular Weight
441.5432
Molecular Formula
C23H27N3O4S
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tomeglovir can be studied extensively for its potential therapeutic applications in the treatment of HCMV infections, particularly in immunocompromised patients (like organ transplant recipients), where the virus can cause severe complications.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.